vs

Side-by-side financial comparison of C4 Therapeutics, Inc. (CCCC) and FRANKLIN WIRELESS CORP (FKWL). Click either name above to swap in a different company.

FRANKLIN WIRELESS CORP is the larger business by last-quarter revenue ($11.9M vs $11.0M, roughly 1.1× C4 Therapeutics, Inc.). FRANKLIN WIRELESS CORP runs the higher net margin — 4.5% vs -186.0%, a 190.4% gap on every dollar of revenue. On growth, C4 Therapeutics, Inc. posted the faster year-over-year revenue change (112.8% vs -33.1%). Over the past eight quarters, C4 Therapeutics, Inc.'s revenue compounded faster (90.4% CAGR vs 39.0%).

C4 Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing targeted protein degradation therapies for cancer and other severe diseases with high unmet medical needs. It leverages its proprietary TORPEDO platform to design small molecule degraders that eliminate disease-causing proteins, with a pipeline of oncology candidates in preclinical and clinical development, plus strategic partnerships with leading global pharmaceutical firms.

Viaero Wireless is a regional wireless telecommunications company that provides direct coverage in Nebraska, eastern Colorado, western Kansas, and southeastern Wyoming. Based in Fort Morgan, Colorado, Viaero is often the primary cell tower owner in portions of its coverage area. Through roaming coverage partner relationships, Viaero customers can place and receive calls locally and across the country, internationally, and on cruise ships.

CCCC vs FKWL — Head-to-Head

Bigger by revenue
FKWL
FKWL
1.1× larger
FKWL
$11.9M
$11.0M
CCCC
Growing faster (revenue YoY)
CCCC
CCCC
+145.9% gap
CCCC
112.8%
-33.1%
FKWL
Higher net margin
FKWL
FKWL
190.4% more per $
FKWL
4.5%
-186.0%
CCCC
Faster 2-yr revenue CAGR
CCCC
CCCC
Annualised
CCCC
90.4%
39.0%
FKWL

Income Statement — Q4 FY2025 vs Q2 FY2026

Metric
CCCC
CCCC
FKWL
FKWL
Revenue
$11.0M
$11.9M
Net Profit
$-20.5M
$533.6K
Gross Margin
17.1%
Operating Margin
-210.1%
0.4%
Net Margin
-186.0%
4.5%
Revenue YoY
112.8%
-33.1%
Net Profit YoY
40.7%
133.3%
EPS (diluted)
$-0.09
$0.05

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CCCC
CCCC
FKWL
FKWL
Q4 25
$11.0M
$11.9M
Q3 25
$11.2M
$12.7M
Q2 25
$6.5M
$6.9M
Q1 25
$7.2M
$8.0M
Q4 24
$5.2M
$17.8M
Q3 24
$15.4M
$13.3M
Q2 24
$12.0M
$6.1M
Q1 24
$3.0M
$6.2M
Net Profit
CCCC
CCCC
FKWL
FKWL
Q4 25
$-20.5M
$533.6K
Q3 25
$-32.2M
$640.5K
Q2 25
$-26.0M
$-342.2K
Q1 25
$-26.3M
$-644.8K
Q4 24
$-34.6M
$228.7K
Q3 24
$-24.7M
$515.2K
Q2 24
$-17.7M
$-1.8M
Q1 24
$-28.4M
$-1.2M
Gross Margin
CCCC
CCCC
FKWL
FKWL
Q4 25
17.1%
Q3 25
22.8%
Q2 25
18.0%
Q1 25
16.9%
Q4 24
18.2%
Q3 24
15.5%
Q2 24
10.5%
Q1 24
8.4%
Operating Margin
CCCC
CCCC
FKWL
FKWL
Q4 25
-210.1%
0.4%
Q3 25
-306.4%
4.6%
Q2 25
-441.0%
-19.0%
Q1 25
-402.9%
-24.6%
Q4 24
-728.4%
4.5%
Q3 24
-183.9%
-2.8%
Q2 24
-178.6%
-36.7%
Q1 24
-1060.2%
-25.2%
Net Margin
CCCC
CCCC
FKWL
FKWL
Q4 25
-186.0%
4.5%
Q3 25
-286.4%
5.0%
Q2 25
-402.6%
-4.9%
Q1 25
-363.7%
-8.1%
Q4 24
-667.8%
1.3%
Q3 24
-160.6%
3.9%
Q2 24
-147.6%
-28.9%
Q1 24
-933.2%
-19.0%
EPS (diluted)
CCCC
CCCC
FKWL
FKWL
Q4 25
$-0.09
$0.05
Q3 25
$-0.44
$0.05
Q2 25
$-0.37
$-0.03
Q1 25
$-0.37
$-0.05
Q4 24
$-0.50
$0.02
Q3 24
$-0.35
$0.04
Q2 24
$-0.26
$-0.16
Q1 24
$-0.41
$-0.10

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CCCC
CCCC
FKWL
FKWL
Cash + ST InvestmentsLiquidity on hand
$74.6M
$24.3M
Total DebtLower is stronger
Stockholders' EquityBook value
$256.6M
$35.1M
Total Assets
$359.1M
$53.0M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CCCC
CCCC
FKWL
FKWL
Q4 25
$74.6M
$24.3M
Q3 25
$58.8M
$25.3M
Q2 25
$78.2M
$25.9M
Q1 25
$51.3M
$25.3M
Q4 24
$55.5M
$21.9M
Q3 24
$59.6M
$40.7M
Q2 24
$73.1M
$37.5M
Q1 24
$89.7M
$31.7M
Stockholders' Equity
CCCC
CCCC
FKWL
FKWL
Q4 25
$256.6M
$35.1M
Q3 25
$154.4M
$35.1M
Q2 25
$174.1M
$34.5M
Q1 25
$195.1M
$35.3M
Q4 24
$216.0M
$36.0M
Q3 24
$242.7M
$35.8M
Q2 24
$247.1M
$35.1M
Q1 24
$258.3M
$36.9M
Total Assets
CCCC
CCCC
FKWL
FKWL
Q4 25
$359.1M
$53.0M
Q3 25
$265.5M
$53.3M
Q2 25
$296.5M
$51.3M
Q1 25
$319.5M
$49.7M
Q4 24
$349.6M
$54.5M
Q3 24
$376.1M
$51.6M
Q2 24
$381.1M
$46.7M
Q1 24
$398.4M
$50.0M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CCCC
CCCC
FKWL
FKWL
Operating Cash FlowLast quarter
$-22.1M
$-4.1M
Free Cash FlowOCF − Capex
$-4.1M
FCF MarginFCF / Revenue
-34.3%
Capex IntensityCapex / Revenue
0.1%
Cash ConversionOCF / Net Profit
-7.66×
TTM Free Cash FlowTrailing 4 quarters
$-9.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CCCC
CCCC
FKWL
FKWL
Q4 25
$-22.1M
$-4.1M
Q3 25
$-31.2M
$-1.5M
Q2 25
$-12.1M
$2.3M
Q1 25
$-33.3M
$-5.9M
Q4 24
$-17.9M
$2.7M
Q3 24
$-24.1M
$2.7M
Q2 24
$-5.0M
$6.2M
Q1 24
$-18.1M
$-779.0K
Free Cash Flow
CCCC
CCCC
FKWL
FKWL
Q4 25
$-4.1M
Q3 25
$-31.6M
$-1.5M
Q2 25
$2.3M
Q1 25
$-5.9M
Q4 24
$-17.9M
$2.7M
Q3 24
$-24.1M
$2.6M
Q2 24
$-5.2M
$6.2M
Q1 24
$-816.0K
FCF Margin
CCCC
CCCC
FKWL
FKWL
Q4 25
-34.3%
Q3 25
-281.5%
-11.7%
Q2 25
33.6%
Q1 25
-73.7%
Q4 24
-346.5%
15.4%
Q3 24
-157.2%
19.9%
Q2 24
-43.1%
101.3%
Q1 24
-13.2%
Capex Intensity
CCCC
CCCC
FKWL
FKWL
Q4 25
0.1%
Q3 25
3.7%
0.0%
Q2 25
0.1%
Q1 25
0.0%
Q4 24
0.1%
0.0%
Q3 24
0.1%
0.2%
Q2 24
1.6%
0.0%
Q1 24
0.0%
0.6%
Cash Conversion
CCCC
CCCC
FKWL
FKWL
Q4 25
-7.66×
Q3 25
-2.32×
Q2 25
Q1 25
Q4 24
11.99×
Q3 24
5.18×
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons